•  
  •  
  •  
  •  

2026-02-13 01:03:00

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Stanley Lifestyles delivers resilient 6.2% gross profit growth in 9MFY26
  • INOX India Ltd announces Q3 & 9M FY26 Results
  • Bonfiglioli Transmissions Limited files DRHP with SEBI for an IPO
  • Calcom Vision reports Highest Ever Quarterly Revenue with 23% YoY growth to Rs 55 crores
  • Savita Oil Technologies Expands Two-Decade Association with Mahindra Group through Strategic Multi-Year Partnership

Keywords Selected:  Revlimid

Research

  • Natco Pharma - Natco and Teva launch Revlimid in the US - ICICI Securities

Stock Report

  • Zydus launches Lenalidomide Capsules
  • Zydus receives final approval from the USFDA for Lenalidomide Capsules 5 mg, 10 mg, 15 mg and 25 mg
  • Dr. Reddy's Laboratories launches Lenalidomide Capsules in the U.S.
  • Cipla receives USFDA approval for generic version of Revlimid®
  • NATCO Launches First Generic Version of Revlimid® in the U.S. market

Latest Post

  • Stanley Lifestyles delivers resilient 6.2% gross profit growth in 9MFY26
  • INOX India Ltd announces Q3 & 9M FY26 Results
  • Bonfiglioli Transmissions Limited files DRHP with SEBI for an IPO
  • Calcom Vision reports Highest Ever Quarterly Revenue with 23% YoY growth to Rs 55 crores
  • Savita Oil Technologies Expands Two-Decade Association with Mahindra Group through Strategic Multi-Year Partnership


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025